HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).

Abstract
2013 was the year of transcatheter heart valve interventions. Not least because of the 2012 European guidelines on the management of valvular heart disease (VHD), the multidisciplinary heart team approach became an established concept. Decision-making, when a patient is too 'sick' for surgery and too 'healthy' for catheter-based interventions, is complex, since VHD is often seen at an older age and, as a consequence, there is a higher frequency of co-morbidity and frailty. However, before TAVI and other transcatheter heart valve interventions can be expanded to intermediate-risk patients, evidence in favour of this less invasive treatment has to be provided by upcoming randomized clinical trials.
AuthorsEberhard Grube, Jan-Malte Sinning, Alec Vahanian
JournalEuropean heart journal (Eur Heart J) Vol. 35 Issue 8 Pg. 490-5 (Feb 2014) ISSN: 1522-9645 [Electronic] England
PMID24385378 (Publication Type: Journal Article)
Topics
  • Cardiac Catheterization (trends)
  • Cardiology (trends)
  • Forecasting
  • Heart Valve Diseases (therapy)
  • Heart Valve Prosthesis (trends)
  • Heart Valve Prosthesis Implantation (trends)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: